News Daily News FDA Panel Declines to Endorse Ventura Interatrial Shunt for HFrEF Panelists considered the technology relatively safe but weren’t swayed by the “statistical gymnastics” needed to find a benefit. Todd Neale December 05, 2025
Presentation Cardiovascular Interventions 2025 Transcatheter Tricuspid Repair and Replacement: Which Therapy and When? Presenter: Matthew J. Price November 13, 2025
Presentation Cardiovascular Interventions 2025 Transcatheter Mitral Valve-in-Valve, Ring, and MAC: Tips, Tricks, and Pitfalls Presenter: Curtiss T. Stinis November 13, 2025
Presentation ESC 2025 Vericiguat in ambulatory patients with chronic heart failure with reduced ejection fraction: Results of the VICTOR trial Presenter: Faiez Zannad August 30, 2025
Presentation ESC 2025 Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction: REBOOT Presenter: Borja Ibanez August 30, 2025
Presentation ESC 2025 DAPA ACT HF – TIMI 68: Dapagliflozin in Patients Hospitalized for Heart Failure Presenter: David D. Berg August 30, 2025
News Daily News FDA Panel Declines to Endorse Ventura Interatrial Shunt for HFrEF By Todd Neale December 05, 2025
News Daily News Rising HF Burden in the US Potentially Related to Changes in Cardiometabolic Factors By Yael L. Maxwell December 02, 2025
News Opinion CV Team Dispatch November 2025 Dispatch for the CV Team By L.A. McKeown November 24, 2025
News Conference News AHA 2025 POLY-HF: Polypill Pays Dividends in Patients With HFrEF By Todd Neale November 14, 2025
News Daily News Déjà Vu All Over Again? Results of Intracoronary Stem Cell Study Questioned By Yael L. Maxwell November 13, 2025